SCARINGI, Lucia
 Distribuzione geografica
Continente #
NA - Nord America 1.771
EU - Europa 1.671
AS - Asia 299
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.744
Nazione #
US - Stati Uniti d'America 1.770
SE - Svezia 451
UA - Ucraina 386
IE - Irlanda 283
IT - Italia 178
HK - Hong Kong 118
VN - Vietnam 97
FI - Finlandia 91
DE - Germania 87
RU - Federazione Russa 71
GB - Regno Unito 52
CN - Cina 38
FR - Francia 26
TR - Turchia 22
BE - Belgio 15
SG - Singapore 11
CH - Svizzera 9
AT - Austria 6
NL - Olanda 6
UZ - Uzbekistan 6
PL - Polonia 4
EU - Europa 3
GR - Grecia 3
JP - Giappone 2
KR - Corea 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
CZ - Repubblica Ceca 1
IR - Iran 1
LB - Libano 1
MX - Messico 1
Totale 3.744
Città #
Chandler 401
Dublin 283
San Mateo 220
Jacksonville 157
Hong Kong 118
Ann Arbor 110
Dong Ket 97
Medford 73
Princeton 72
Wilmington 65
Des Moines 63
Andover 53
Ashburn 39
Perugia 30
Woodbridge 29
Altamura 28
Saint Petersburg 28
Beijing 27
Lawrence 23
Helsinki 20
Izmir 17
Boardman 16
Brussels 15
Norwalk 14
Singapore 9
Auburn Hills 8
San Diego 7
Tavernelle 7
Den Haag 6
Falls Church 6
Denizli 5
Dearborn 4
Florence 4
Moscow 4
Redmond 4
Hanover 3
Hebei 3
Los Angeles 3
Milan 3
San Paolo di Civitate 3
Santi Cosma E Damiano 3
Bagnoli Di Sopra 2
Bettona 2
Biancavilla 2
Bologna 2
Bratislava 2
Civitanova Marche 2
Civitavecchia 2
Fremont 2
Houston 2
Lausanne 2
Molfetta 2
New York 2
Shanghai 2
Tokyo 2
Ancona 1
Aosta 1
Ardabil 1
Bollate 1
Dallas 1
Faenza 1
Frankfurt Am Main 1
Lucca 1
Marcianise 1
Nanjing 1
Nanning 1
Olevano Romano 1
Parma 1
Redwood City 1
Rimini 1
Rome 1
Saludecio 1
Saronno 1
Seoul 1
Simi Valley 1
Sulmona 1
Tappahannock 1
Valle 1
Vedelago 1
Yerevan 1
Zurich 1
Totale 2.134
Nome #
Effetti dell’infezione intracellulare da streptococco di gruppo B sierotipo Ia nel macrofago 180
Activity inhibition of cytolytic lymphocytes by omeprazole. 117
Local and systemic immune response to inactivated C. albicans in mice 101
Effects of hydrogen peroxide on both proliferative capacity and vitality of different animal species lymphocytes 100
Activation of cytokine genes during primary and anamnestic immune response to inactivated C. albicans 95
Cytokine response to inactivated Candida albicans in mice 90
Cytokine response to group B streptococcus infection in mice 84
Attività adiuvante della Candida albicans inattivata nel topo. 83
Combined effects of cyclophosphamide and thymostimulin treatment on the in vitro natural killer and candidacidal activity of murine spleen cells. 81
Group B Streptococcus induces apoptosis in macrophages 80
Omeprazole induces apoptosis in normal human polymorphonuclear leucocytes 76
Local and systemic immune response to inactivated Candida Albicans in mice. 75
In vitro effects of Meropenem and Imipenem/Cilastatin on some functions of human natural effector cells 74
Inibizione della attività NK da parte dell’omeprazolo 72
Omeprazole induces apoptosis in Jurkat cells 69
Induction and persistence in vivo of NK/LAK activity by a mannoprotein component of Candida albicans cell wall. 68
Antioxidant systems and lymphocyte proliferation in the horse, sheep and dog 68
[Immune response to a histocompatible murine lymphoma. Synergism with chemotherapy] 63
Immunochemotherapy of a murine lymphoma: influence of tumor load 63
Cytokine gene expression during in vivo induction of natural killer/lymphokine activated killer cells by inactivated C. albicans cells 63
Effect of inactivated C. albicans on natural killer (NK) cell activity and blastogenesis in mice. P. Marconi, L. Scaringi, A. Cassone, L. Tissi. In: Genetic and Phenotypic Markers of Tumors, (S.A. Aaronson, L. Frati and R. Verna Eds.). Plenum Publishing Corp., New York, London, pp. 145-151, 1985. 63
Learning from other diseases: protection and pathology in chronic fungal infections 62
Towards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis 62
Antibody-independent protection in mice against type Ia group B streptococcus lethal infection. 60
Tetanus toxin interaction with immune system of mice. 58
Suppression of Friend leukemia cell-induced tumours by cellular preparations of Candida albicans. 57
Macrophage apoptosis induced by Group B Streptococcus 57
Cell wall components of Candida albicans as immunomodulators:induction of natural killer and macrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions. 56
Induction of natural killer cell activity by inactivated Candida albicans in mice. 55
Attivazione sistemica nel topo di cellule NK/LAK mediante C. albicans inattivata in combinazione con interleuchina-2 ricombinante (rIL-2) 55
Fungicidal activity of Candida albicans-induced murine lymphokine-activated killer cells against C.albicans hyphae in vitro. 55
Modulation of immune reactivity by inactivated C. albicans and insoluble glucan-ghost. 54
Citochine nella risposta immune primaria e secondaria verso la C. albicans inattivata 54
A rapid Candida albicans hyphal-form growth inhibition assay: determination of myelomonocytic-mediated antifungal activity. 52
Hepathocyte stimulatory factor III(HBSFIII) human interleukin for DA-1a cells(HLDA) mRNA expression in human hepatoma (HEPG2)Cells. 51
In-vitro effects of teicoplanin, teicoplanin derivative MDL 62211 and vancomycin on human polymorphonuclear cell function. 51
Correlazione fra la induzione nel topo della espressione genica di citochine da parte della C. albicans inattivata ed attivazione di cellule NK/LAK 50
Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans. 48
Group B streptococci persist inside macrophages. 47
Espressione di geni per le citochine ed attivazione di cellule NK/LAK da parte della C. albicans inattivata 47
Eventi immunologici precoci nella risposta immune alla C. albicans inattivata 47
Combined effects of chemotherapy and host antitumor response in a murine histocompatible lymphoma model. 46
Hepatocyte Stimulatory Factor III (HSF III) Human Interleukin for DA 1a cells (HILDA) mRNA Expression in Human Hepatoma (HEP G2) cells 46
Citochine infiammatorie in risposta alla C. albicans inattivata 45
Induzione nel topo da parte della Candida albicans inattivata di cellule con attività citotossica naturale non specifica. 43
[Immunostimulation with inactivated Candida albicans and chemotherapy in murine lymphoma] 42
Induction of natural killer cell activity by inactivated Candida albicans in mice. 41
In vitro production of leukemia inhibitor factor (LIF)by Hep G2 hepatoblastoma cells. 41
In vivo modulation of lymphokine-activated killer cell activity by cell wall components of candida albicans. 40
Cytokine gene expression during primary and anamnestic immune response to inactivated C. albicans 40
Combined effects of chemotherapy and host antitumor response in a murine histocompatible lymphoma model. 40
Lymphokine-activated killer (LAK)-like cells induced in mice after repeated intraperitoneal injections of inactivated Candida albicans. 39
Modulazione in vivo dell’attività NK/LAK mediante una mannoproteina parietale di C. albicans 39
Cytokine response to group B streptococcus infection in mice 38
Omeprazole inhibition of natural killer cytotoxicity 36
Persistent in vivo activation of NK/LAK cells by inactivated C. albicans and its mannoprotein fraction 36
Modulazione in vitro di alcune frazioni immuni da parte della tossina tetanica. 33
Inhibition activity of human cytolytic lymphocytes in vitro by omeprazole 32
In vitro production of leukemia inhibitory factor (LIF) by HEP G2 hepatoblastoma cells 31
Pathogenic effects of group B streptococcus on macrophages 30
Immunostimolazione non specifica con Candida albicans inattivata e chemioterapia in un linfoma murino. Chemioterapia. International Journal of the Mediterranean Society of Chemotherapy, 2 (supp. 3): 261-263, 1983. 30
[Immune response to a histocompatible murine lymphoma. Synergism with chemotherapy]. 29
[Immunostimulation with inactivated Candida albicans and chemotherapy in murine lymphoma]. 28
Caratterizzazione della reattività naturale cellulo-mediata indotta da ciclofosfamide verso la Candida albicans nel topo 28
Produzione in vivo di citochine da parte della C. albicans inattivata ed induzione di cellule NK/LAK 27
Una mannoproteina di parete di C. albicans come modulatore in vivo dell’attività delle cellule NK/LAK 26
Induzione di attività citolitiche naturali nel topo da parte della Candida albicans inattivata e sue frazioni. p. 404-405, 1983. 26
Inibizione in vitro dell’attività citotossica dei linfociti citolitici da parte dell’omeprazolo 23
Polysaccharides secreted by streptococci are able to modulate mouse natural responses. 23
Inactivated Candida albicans and immunostimulation. P. Marconi, L. Scaringi, L. Tissi, A. Cassone, F. Bistoni. In: Agriculture. Adjuvants, Interferon and Non-Specific Immunity. Report EUR 8675 EN. (F.M. Cancellotti and D. Galassi Eds.). pp. 143-152, 1984. 23
Induction of peritoneal natural killer (NK) cell activity by inactivated Candida albicans (CA). L. Tissi, L. Scaringi, F. Bistoni, A. Cassone, M. Boccanera, P. Marconi. 22
Effects of exocellular glucans from streptococci on murine natural reactivity. In: .) 117- 118, 1985. 21
Totale 3.887
Categoria #
all - tutte 12.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.421


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201929 0 0 0 0 0 0 0 0 0 0 27 2
2019/2020326 13 1 49 7 40 9 61 6 69 33 4 34
2020/2021855 5 66 54 65 186 82 48 3 109 52 65 120
2021/2022773 28 167 16 77 39 9 8 212 8 29 61 119
2022/20231.114 89 134 8 108 104 182 0 45 401 0 28 15
2023/2024308 24 49 41 9 1 2 85 33 44 6 14 0
Totale 3.887